API: Industrial Upgrading, Industrial Extension

As always, the 14th Five-Year Plan emphasises the green development of the API industry, pointing out that as the pharmaceutical industry moves towards a new stage of development, the issue of green production and layout of APIs still needs to be addressed. In the new stage of development, the issue of green production and layout of APIs still needs to be addressed. At the same time, in terms of enhancing the stability and competitiveness of the industry The 14th Five-Year Plan has put forward clearer guidelines on the development trend of the API industry in terms of improving the stability and competitiveness of the industry chain. The 14th Five-Year Plan provides clearer guidelines for the development trend of the API industry. 

Specialty APIs further develop and grow:

Accelerate the development of a number of specialty APIs with high market potential and high technical threshold new varieties of colour APIs and new types of products such as nucleic acids and peptides.

CDMO to drive the development of proprietary APIs:

Vigorously develop the contract manufacturing business of APIs for patented drugs and promote Promote the extension of the API industry to a higher value chain.

Take advantage of the forward integration of APIs and formulations

Building on the API foundation to create "API + Formulation Integrated advantages